Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542â3
Academic Article
Publication Date:
2016
Iris type:
1.1 Articolo in rivista
Keywords:
Adjuvants, Immunologic; Humans; Kidney Neoplasms; Protein-Tyrosine Kinases; Carcinoma, Renal Cell; Nephrectomy; Urology
List of contributors:
Santoni, Matteo; Scarpelli, Marina; Lopez beltran, Antonio; Cheng, Liang; Briganti, Alberto; Montorsi, Francesco; Montironi, Rodolfo; Santini, Daniele
Published in: